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Abstract
There are an estimated 2.5 million people in the United States of America suffering from opioid use disorders.
Of the 2.5 million Americans impacted by opioid use disorders, over half are women. One of the most
challenging aspects of opioid use disorders occurs in the context of pregnancy. Discourse surrounding the
topic of addiction often identifies the root cause of addiction as a moral failing, rather than a
pathophysiological disease. This stigma is amplified in the context of pregnancy and perpetuates the false,
discriminatory notion that pregnant women with opioid use disorders are knowingly “harming” their babies
without regard.
Instead of receiving support, education, and encouragement, pregnant women with opioid use disorders are
faced with stigma, judgment, shame, and guilt. These negative interactions ultimately serve as barriers that
interfere with the ability for early attachment bond development, a monumentally important piece of
newborn development and the most significant contributor to healthy attachment development. These
avoidable, institutionally created barriers propagate both short- and long-term risk factors for the mother and
infant, both independently and as a dyad.
This dissertation will systematically explore several aspects of perinatal opioid use disorders to develop an
evidence-informed practice model for healthcare providers working with pregnant and postpartum women
with opioid use disorders. This dissertation will also explore the intersection of perinatal opioid use disorders
and attachment theory, which will serve as the framework for the PARTNER model, an attachment-based
practice model for providers working with mothers and infants impacted by perinatal opioid use disorders.
Composite case vignettes, informed by clinical experience and empirical literature, are integrated throughout
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THE	STIGMA	OF	OPIOID	DEPENDENCY	AND	ADDICTION	Despite	historical	implications,	scientific	evidence	that	distinguishes	an	opioid	use	disorder	as	a	pathology-driven	disease,	and	empirically	identified	risk	factors	associated	with	opioid	use	disorders,	the	stigma	surrounding	opioid	dependency	and	addiction	is	palpable.		The	concept	of	social	stigma	was	first	explored	and	defined	by	sociologist,	Erving	Goffman.	Goffman	identified	stigma	as	a	phenomenon	involving	perceptual	classification	of	people	as	either	normal	or	undesirable	based	on	societally-constructed	beliefs.	Goffman	also	identified	three	groups	of	people	related	to	a	stigma:	1) the	stigmatized,	characterized	by	individuals	or	groups	who	are	associated	with	and	impacted	by	the	stigma,	2) the	normals,	characterized	by	individuals	or	groups	who	are	not	associated	with	nor	impacted	by	the	stigma,	and	3) the	wise,	characterized	by	individuals	or	groups	who	are	not	associated	with	nor	impacted	by	the	stigma,	but	are	fundamentally	aware	of	the	stigma	and	the	way	in	which	it	impacts	the	stigmatized	(Goffman,	1963).		Empirical	research	has	supported	Goffman’s	theory,	with	the	identification	of	two	subgroups	that	exist	within	the	wise:		
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INTRODUCTION	TO	THE	PARTNER	MODEL		 This	chapter	will	provide	a	layout	of	the	PARTNER	model	including	an	overview,	key	elements,	significance,	and	application	to	practice.	The	following	chapter	will	include	a	case	study	that	provides	examples	of	how	each	of	the	elements	should	be	integrated	into	healthcare	provider	practice.	The	PARTNER	model	is	comprised	of	seven	key	elements	of	attachment-focused	care,	including:	1. Person-Centered		2. Attachment-Informed	3. Risk	Reduction	4. Trauma-Informed	5. Neutrality	6. Empowerment	7. Reinforcement	All	of	these	elements	are	intended	to	be	integrated	simultaneously	and	seamlessly	into	care.	The	model	emerged	from	an	understanding	of	risk	factors	for	opioid	use	disorder,	barriers	to	prenatal/postnatal	care,	and	ways	to	address	these	issues	with	a	focus	on	fostering	attachment	not	just	by	developing	a	partnership	between	mother	and	baby,	but	also	between	mother	and	the	care	providers.	Each	element	has	a	common	goal	of	educating,	reducing	stigma,	and	fostering	attachment.	These	components	can	certainly	be	applied	to	anyone	with	a	history	of	addiction,	but	this	model	is	specifically	designed	for	pregnant	and	postpartum	women	currently	struggling	with	addiction,	as	it	specifically	addresses	the	unique	needs	of	this	population	as	uncovered	in	the	literature.		
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THE	PARTNER	MODEL	IN	ACTION		 Throughout	the	PARTNER	model	analysis,	vignettes	from	Kiana’s	composite	case	study	are	incorporated	to	illustrate	how	the	elements	of	the	PARTNER	model		are	implemented	in	practice.	To	reintroduce	Kiana,	she	is	a	23-year-old	black,	heterosexual,	cisgender	woman	with	a	perinatal	opioid	use	disorder.	Kiana	currently	lives	in	Philadelphia	with	her	mother	and	two	younger	sisters	and	works	long,	late-night	hours	a	restaurant.	She	has	several	risk	factors	linked	to	substance	use	disorders,	including	a	family	history	of	alcohol	abuse,	mental	illness,	and	domestic	violence,	all	of	which	contribute	to	Kiana’s	ACE	score	of	8/10.	Kiana	has	also	been	diagnosed	with	depression	and	has	experienced	sexual	violence	in	adulthood.		Kiana	was	first	introduced	to	opiates	at	age	20,	when	she	was	given	a	prescription	for	Percocet	after	getting	into	a	car	accident.	Without	having	any	education	on	opioid	risks,	she	took	the	Percocet	prescription	every	day	for	two	months.	Unfortunately,	a	handful	of	missed	opportunities	helped	to	create	a	pipeline	to	addiction.	Kiana	never	got	psychoeducation	on	the	risk	of	opioids	or	an	evaluation	for	opioid	dependency.	Kiana	was	met	with	stigma	and	judgment	rather	than	support	and	unbiased	care.	It	was	only	a	matter	of	weeks	before	Kiana	became	physically	dependent	and	behaviorally	addicted	to	opioids.	Eventually,	Kiana	transitioned	from	Percocet	to	heroin.		Three	years	after	being	introduced	to	opiates,	Kiana	experienced	her	first	overdose.	She	was	treated	with	NARCAN	and	brought	to	the	hospital	for	an	evaluation	and	workup.	It	was	during	this	emergency	department	visit	that	Kiana	found	out	she	was	12	weeks	pregnant.	Kiana’s	story	continues	from	here,	at	which	time	she	is	treated	by	providers	who	are	working	from	the	PARTNER	model	approach.	By	integrating	the	PARTNER	model	
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approach	into	their	practice,	Kiana’s	healthcare	providers	are	able	to	meet	Kiana	where	she	is,	identify	her	strengths,	and	help	her	develop	an	early	attachment	bond	with	her	baby	by	meeting	her	where	she	is	and	providing	her	with	person-centered,	unbiased,	ethical	medical	care.		
P:	PERSON-CENTERED	The	first	element	of	the	PARTNER	model	is	person-centered.	A	person-centered	approach	is	characterized	by	the	establishment	of	equal	partnership	between	the	provider	and	the	patient	that	is	rooted	in	genuine	empathy	for	individually	lived	experiences.	Equal	partnership	is	the	foundation	of	the	person-centered	approach.	It	requires	providers	to	view	the	patient	as	an	individual	person	with	individual	needs,	leaving	behind	the	one-size-fits-all	mentality.	This	approach	is	vital	to	this	practice	model,	as	it	supports	the	overarching	goal	to	educate,	destigmatize,	and	foster	attachment	as	equal	partners	in	planning	rather	than	from	an	imbalanced	power	approach.	The	provider	and	patient	still	have	their	unique	roles	within	the	relationship,	but	it	is	more	collaborative	in	nature	than	a	traditional	directive	healthcare	approach.	When	working	from	this	framework,	providers	act	as	guides	or	coaches	in	informed	healthcare	decision-making.	This	also	requires	providers	to	acknowledge	the	power	dynamics	that	exist	within	the	patient/provider	relationship,	which	can	often	act	as	barriers	to	developing	this	equal	partnership.	The	benefits	of	creating	this	partnership	can	also	surpass	pregnancy,	as	it	can	open	an	ongoing	doorway	to	developing	and	maintaining	a	safe,	comfortable	relationship	with	health	care	systems	in	general.		Person-centered	care	also	requires	providers	to	respect	and	appreciate	the	patient’s	world,	free	from	judgment	or	stigmatization.	The	empathy	involved	in	person-centered	
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care	goes	beyond	understanding	feelings;	it	requires	a	capacity	for	deeper	understanding	and	acceptance	of	the	patient’s	lived	experiences	from	the	patient’s	individual	life	paradigm.	Through	this	approach,	providers	can	capture	a	patient’s	true	narrative	by	allowing	the	patient	to	guide	and	process	the	narrative	themselves.	It	is	a	holistic	approach	that	requires	providers	to	meet	the	patient’s	needs	in	a	way	that	is	applicable	to	the	patient’s	uniquely	lived	experiences.		
CASE	STUDY	VIGNETTE	
Kiana	was	brought	to	the	hospital	after	overdosing	on	heroin.	She	is	laying	on	a	
stretcher	in	an	emergency	department	room,	feeling	ashamed,	embarrassed,	and	
completely	overwhelmed.	She	has	just	been	told	that	she	is	pregnant,	approximately	12	
weeks’	gestation.	Per	hospital	protocol,	Kiana	is	admitted	to	the	maternal/fetal	
medicine	unit	for	withdrawal	monitoring	and	treatment,	which	involves	medication-
assisted	treatment	initiation.	Allison,	a	licensed	clinical	social	worker,	has	been	
consulted	to	meet	with	Kiana	and	complete	an	initial	assessment	using	the	PARTNER	
model	to	guide	her	approach.	
Allison	knocks	on	the	door,	asking	permission	to	enter	the	room	and	sit	in	the	
open	chair	next	to	Kiana’s	stretcher.	Allison	introduces	herself	and	reviews	her	role	as	
the	perinatal	clinic	social	worker.	Allison	explains	to	Kiana	that	she	is	here	to	meet	
with	her,	provide	support,	and	talk	through	some	questions	to	determine	how	she	can	
be	the	most	helpful.	Allison	explains	that	she	is	going	to	ask	Kiana	several	questions.	
“Kiana,	if	at	any	point	you	feel	overwhelmed	or	uncomfortable,	just	let	me	know.	I	
know	you’ve	had	a	really	tough	day,	so	we	will	move	at	whatever	pace	feels	the	most	
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comfortable	for	you.	We	can	take	a	break	or	stop	at	any	time.	Does	this	sound	okay	
with	you?”	
At	this	point	in	the	interaction,	Kiana	feels	anxious	and	ashamed.	However,	
Allison’s	empathic	understanding	approach	helps	to	put	her	at	ease.	Allison	is	using	a	
person-centered	approach	to	engage	Kiana	and	lay	the	groundwork	for	the	
development	of	an	equal	partnership	between	Kiana	and	her	healthcare	providers.	She	
is	showing	respect	for	Kiana’s	physical	and	mental	space	by	asking	for	permission	to	
enter	the	room	and	putting	the	control	of	the	assessment	pace	in	Kiana’s	hands.	
	 Throughout	the	assessment,	Kiana	reveals	clinically	significant	aspects	of	her	
life	that	have	been	empirically	identified	as	risk	factors	for	opioid	dependency.	Allison	
is	engaged	in	active	listening,	providing	empathic	validation	while	assessing	for	
Kiana’s	needs.	Allison	also	discusses	pregnancy	options	(parenting,	adoption,	and	
termination)	without	making	any	assumptions,	practicing	from	a	collaborative,	rather	
than	authoritative,	approach.	Kiana	shares	that	she	would	like	to	move	forward	with	
the	pregnancy	and	parent	her	baby	but	does	not	know	where	to	start.	
Allison	introduces	the	opportunity	to	help	connect	Kiana	to	an	ob/gyn	for	
prenatal	care	and	medication-assisted	treatment	programs,	discussing	all	of	the	
options	with	her.	Kiana	expresses	interest	in	initiating	this	type	of	treatment.	Allison	
asks	Kiana,	“We’ve	talked	about	a	few	different	programs.	Based	on	what	you’ve	told	
me	about	you,	I	think	the	buprenorphine	clinic	that	specializes	in	perinatal	health	
would	be	great	for	you.	What	do	you	think?”	Again,	by	taking	this	approach,	Allison	
practicing	from	a	collaborative,	rather	than	authoritative,	approach.	She	is	creating	
an	equal	partnership	with	Kiana	and	is	giving	her	autonomy	in	evaluating	her	
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healthcare	decisions.	Kiana	agrees	to	starting	buprenorphine	medication-assisted	
treatment	management	with	the	perinatal	addiction	clinic.	Allison	provides	a	warm	
handoff	to	both	the	perinatal	addiction	clinic	and	outpatient	ob/gyn	clinic	teams.		
	
A:	ATTACHMENT-INFORMED	The	second	element	of	the	PARTNER	model	is	attachment-informed.	An	attachment-
informed	approach	involves	integrating	support,	psychoeducation,	and	engagement	that	fosters	relationship	building	between	providers	and	the	patient,	as	well	as	the	patient	and	the	baby.	The	empirical	research	uncovered	has	revealed	that	incorporating	psychosocial	factors	like	breastfeeding,	bonding,	swaddling,	cuddling,	and	family	involvement	improves	outcomes	for	infants	with	intrauterine	opioid	exposure.	The	literature	also	reveals	that	additional	psychosocial	factors,	like	nurturing,	supportive,	stable	homes	with	social	and	family	protective	factors,	provide	further	improved	short-	and	long-term	physical	and	behavioral	outcomes	for	these	infants	and	their	families.	Each	of	these	factors,	though	individually	beneficial,	are	all	linked	by	an	extremely	significant	common	denominator.	They	are	all	components	of	early	attachment	development.		Although	there	are	several	generalizable	infant	cues	(for	example,	crying	when	hungry),	each	infant	communicates	differently	than	the	other.	Neonatal	abstinence	syndrome	can	play	a	significant	role	in	this	attachment	development	and	the	way	in	which	babies	interact	with	their	attachment	figures.	Symptoms	of	NAS	directly	impact	the	way	in	which	the	baby	eats,	sleeps,	and	cries.	Infants	initially	utilize	crying	as	a	form	of	expression,	but	eventually	crying	becomes	the	infant’s	primary	mode	of	communication	with	the	mother.	This	is	the	infant’s	primary	and	initial	form	of	communication	with	the	mother.	
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The	infant’s	cry	initiates	physiological	responses	within	the	mother	that	induce	breastmilk	production.	A	mother	can	develop	an	incredibly	strong	bond	with	her	child	as	she	learns	to	speak	her	child’s	language.	Eye	contact,	physical	contact,	and	verbal	contact	are	all	key	elements	of	attachment	development	between	the	mother	and	infant.	To	develop	a	strong	attachment	bond,	these	activities	must	be	consistent	and	reliable.	Consistency	is	predictable	and	inherently	safe.	This	is	an	important	consideration	when	working	from	an	attachment-informed	framework	to	foster	partnership	between	the	mother	and	her	baby,	as	well	as	the	mother	and	her	providers.		
CASE	STUDY	VIGNETTE	
Kiana	presents	to	the	ob/gyn	clinic	office	for	her	first	prenatal	care	visit.	Kiana	
looks	around	and	sees	several	other	pregnant	women	in	the	waiting	room.	Kiana	
wonders	to	herself,	“Do	I	even	belong	here?	Do	I	even	deserve	to	be	a	mom?”	Kiana	
timidly	approaches	the	front	desk	to	start	the	check-in	process.	Terrie,	the	ob/gyn	
practice	manager,		greets	her	with	a	warm	smile.		
“Hi	Kiana,	thank	you	so	much	for	coming	to	see	us	today.	How	are	you	feeling?”	
“I’m	okay,	thanks,”	Kiana	responds.	Kiana	still	feels	hesitant	but	notices	a	sense	of	
relief.	“We	have	some	paperwork	for	you	to	fill	out,”	Terrie	says.	“Take	your	time,	no	
rush.	If	you	have	any	questions,	just	let	me	know.	I’m	here	to	help.”	Terrie	
acknowledges	the	imbalanced	power	dynamic	that	exists	between	healthcare	
providers	and	patients.	She	is	engaging	Kiana	from	an	attachment	perspective,	
utilizing	a	nurturing,	supportive	approach.		
After	her	paperwork	is	completed,	Kiana	is	greeted	by	Beth,	one	of	the	ob/gyn	
office	nurses.	Beth	walks	Kiana	back	to	the	patient	room	and	completes	her	vitals.	Beth	
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asks	Kiana	if	she	has	any	questions	or	concerns	that	she	would	like	to	address	during	
her	visit	today.	Kiana	has	more	questions	than	she	can	count,	but	she	quietly	responds,	
“I’m	not	really	sure.”	Beth	recognizes	that	this	is	a	stressful,	intimidating	situation	for	
Kiana.	To	normalize	Kiana’s	feelings,	Beth	responds,	“That’s	okay.	I	don’t	know	any	
new	moms-to-be	who	know	exactly	where	to	start.	There’s	so	much	to	think	about!	
Why	don’t	we	start	with	what	to	expect	for	this	visit?”	Beth	provides	Kiana	with	an	
overview	of	the	first	prenatal	care	visit.	Like	Terrie,	she	is	engaging	Kiana	from	an	
attachment	perspective,	utilizing	a	nurturing,	supportive	approach.		
Shortly	after	Beth	leaves	the	room,	Dr.	Ziegel	knocks	on	the	door,	asks	
permission	to	enter	the	room.	“Hi	Kiana,	it’s	so	nice	to	meet	you.	My	name	is	Dr.	Ziegel,	
but	everyone	calls	me	Jenny,”	she	says.	During	Jenny’s	evaluation	and	assessment,	she	
asks	Kiana	some	questions	about	her	opioid	use	disorder	history	and	the	newly	
initiated	medication-assisted	treatment	management.	Kiana	states	has	been	working	
well	for	her	thus	far,		but	Jenny	notices	Kiana	appears	visibly	upset.	Jenny	asks,	“What’s	
going	through	your	mind,	Kiana?”	Kiana	replies,	“What’s	going	to	happen	to	my	baby?”	
Jenny	takes	the	time	to	answer	all	of	Kiana’s	questions.	Jenny	explains	the	
different	ways	in	which	opiates	and	buprenorphine	interact	with	the	baby	in	utero,	
reassuring	Kiana	that	the	baby	is	safer	with	the	medication	assisted	treatment.	Jenny	
provides	education	on	neonatal	abstinence	syndrome,	explaining	the	diagnosis	and	
treatment	process.	Jenny	also	provides	education	on	mandated	reporting	laws,	
explaining	that	the	hospital	is	legally	required	to	notify	child	protective	services	of	any	
unprescribed	opioid	use	during	pregnancy.	Jenny	also	emphasizes	the	impactful	role	of	
maternal	engagement	and	attachment	bonding	activities	in	the	NAS	treatment	
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process.	By	doing	this,	Jenny	is	laying	the	groundwork	for	early	attachment	bond	
development.	Jenny	is	thoroughly	explaining	all	aspects	of	the	perinatal	opioid	
dependency,	but	discusses	these	sensitive	topics	using	supportive,	unthreatening,	
approach.	The	goal	is	to	foster	inclusion	and	partnership	rather	than	fear	and	
disconnection.	Jenny	is	letting	Kiana	know	that	she	is	not	only	deserving	of	being	a	
mother,	but	she	is	needed	and	an	important	part	of	the	baby’s	treatment	team.		
R:	RISK	REDUCTION	The	third	element	of	the	PARTNER	model	is	risk	reduction.	Engaging	in	a	risk	reduction	approach	involves	working	together,	with	the	patient,	toward	the	establishment	of	safety	and	improvements	rather	than	perfection.	Risk	reduction	involves	realistic,	sustainable	goal	setting	with	realistic,	individualized	expectations,	as	well	as	identifying	and	mitigating	barriers	to	achieving	these	goals.	Goal-setting	can	include,	and	is	not	limited	to,	discussions	surrounding	treatment,	parenting,	child	protective	services.	These	goals	can,	and	likely	will,	evolve	throughout	the	pregnancy	and	postpartum	periods.	By	guiding	the	patient	through	the	thought	process	of	goal-setting,	providers	can	help	set	the	patient	up	for	successful	outcomes.	A	patient’s	goals	should	be	augmented	by	psychoeducation	to	ensure	informed	decision-making.	This	is	especially	important	when	discussing	harm	reducing	practices	in	blood	borne	infectious	diseases	and	overdose	prevention.		Again,	risk	reduction	works	toward	establishing	safety	and	improvements	rather	than	perfection.	This	is	important	for	the	provider	to	consider	as	well,	not	just	the	patient.	Research	shows	that	providers	can	expect	some	degree	of	noncompliance	and	inconsistency	in	care	planning	with	people	who	suffer	from	addiction	(Tkacz,	Severt,	Cacciola,	&	Ruetsch,	2011).	Providers	should	respect,	acknowledge,	and	appreciate	any	
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preexisting	and	ongoing	challenges	of	a	patient’s	lived	experiences.	Providers	should	also	respect	patient’s	right	to	disclose	sensitive	information	and	accept	that	patient	may	not	always	be	forthcoming,	especially	given	the	context	of	the	heavy	stigma	surrounding	pregnancy	and	addiction.	Maintaining	realistic	expectations	supports	the	person-centered	approach	and	reduces	occurrence	of	stigma,	as	it	recognizes	and	respects	each	individual	patient’s	abilities,	strengths,	and	needs.	A	patient’s	care	planning	noncompliance	is	not	indicative	of	flawed	character	or	moral	failing	and	should	be	approached	accordingly.			Identifying	and	mitigating	barriers	to	care	is	an	essential	component	of	this	process,	as	barriers	to	care	often	contribute	to	health	care	noncompliance.	Barriers	to	care,	such	as	lack	of	transportation,	medical	insurance,	housing,	and	other	resources	are	significantly	more	likely	to	be	lost	to	care	than	those	patients	who	have	their	basic	needs	met.	In	cases	where	barriers	do	not	have	an	identifiable	or	viable	solution,	providers	should	consider	referring	out	to	external	agencies	for	ongoing	case	management	support.	It	may	not	be	possible	to	mitigate	all	barriers	to	care,	but	again,	the	aim	should	be	toward	improvement,	not	perfection.		
CASE	STUDY	VIGNETTE	
Kiana	returns	to	the	ob/gyn	office	next	prenatal	appointment.	Kiana	is	greeted	
by	her	doctor,	Jenny,	with	a	warm	smile.	“It’s	so	great	to	see	you	again,	Kiana.	Thank	
you	for	coming	to	see	us	today.”	After	her	prenatal	exam	and	labs	are	completed,	
Kiana	anxiously	shares	with	Jenny	that	she	experienced	a	brief	relapse	last	week.	
Kiana	is	terrified	and	embarrassed	to	admit	this,	as	she	does	not	want	anyone	to	think	
she	does	not	love	her	baby.	However,		the	consistently	nonjudgmental	engagement	
Kiana	experiences	with	her	healthcare	team	helps	her	feel	more	comfortable	sharing	
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this.	Jenny	acknowledges	and	commends	Kiana	for	her	bravery	in	sharing	this	
information.	
	Jenny	is	well-versed	in	opioid	use	disorders	and	understands	that	relapse	is	an	
anticipated,	commonly	experienced	aspect	of	the	recovery	process.	Jenny	approaches	
her	practice	with	an	aim	for	improvement,	not	perfection.	Jenny	also	practices	from	a	
disease-model	approach,	making	sure	to	emphasize	to	Kiana	that	this	relapse	is	part	of	
the	process,	not	a	moral	failing	or	character	flaw.		
Jenny	provides	Kiana	with	some	brief	supportive	counseling,	motivational	
interviewing	techniques,	and	psychoeducation	on	the	opioid	addiction	recovery	
process.	Jenny	also	reviews	some	additional	risk	reduction	information,	including	
education	about	needle	sharing	and	needle	exchanges.	Her	goal	is	to	keep	Kiana	and	
her	baby	as	safe	as	possible.	Jenny	also	asks	some	questions	to	assess	for	access	to	basic	
needs	and	barriers	to	care,	uncovering	that	Kiana	is	having	a	hard	time	navigating	
WIC	program	benefits.	Jenny	offers	to	send	a	referral	to	local	non-profit	agency	that	
provides	case	management	supports	to	pregnant	women	with	opioid	use	disorders,	
which	Kiana	accepts.		
	
T:	TRAUMA-INFORMED		 The	fourth	element	of	the	PARTNER	model	is	trauma-informed.	Practicing	from	a	trauma-informed	approach	involves	the	establishment	safety	between	the	patient	and	the	provider	through	connection	and	authenticity.	Safety	is	the	cornerstone	of	attachment	development.	Creating	a	sense	of	basic	safety	is	necessary	for	patients	to	feel	comfortable	with	engaging	with	their	healthcare	providers.	Successfully	establishing	safety	is	heavily	
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dependent	on	the	patient’s	individual	trauma	history	and	attachment	style,	but	providers	can	continuously	work	toward	creating	physical	and	emotional	safety	within	the	patient/provider	relationship	(Sanders	&	Hall,	2018).	Patients	need	to	feel	physically	safe	within	the	immediate	space	between	themselves	and	the	providers.	Patients	also	need	to	feel	emotionally	safe	within	the	patient/provider	relationship.	Emotional	safety	can	be	established	through	the	use	of	clear,	calm	communication,	as	well	as	mindfulness	of	verbal	and	non-verbal	language.	Patients	need	to	feel	safe	simply	being	themselves.		To	develop	this	kind	of	close	relationship	with	a	patient,	it	is	ethically	imperative	that	the	relationship	is	authentic,	genuine,	and	trustworthy.	Providers	should	take	the	time	to	learn	their	patient’s	preferences,	strengths,	needs,	and	values	and	integrate	these	factors	into	care	planning.	This	approach	also	requires	implementation	of	cultural	considerations,	which	aids	in	solidifying	the	respect	for	individual	life	and	identity.	Within	the	context	of	this	authentic	relationship,	patients	learn	to	trust	their	providers,	which	results	in	stronger	engagement	and	relationship-building.	Establishing	an	authentic	relationship	promotes	transparency,	respect,	and	humane	care.	
CASE	STUDY	VIGNETTE	
Kiana	presents	to	the	hospital	for	her	scheduled	induction	of	labor.	Kiana	first	
meets	with	her	nurse,	Kerry,	who	notices	that	Kiana	is	visibly	nervous.	Kiana	is	looking	
down	at	her	hands,	fidgeting,	and	avoiding	eye	contact.	Kerry	greets	Kiana	with	
warmth,	kindness,	and	reassurance.	Kerry	understands	the	importance	of	building	an	
authentic,	genuine	rapport	with	Kiana	to	foster	trust	and	safety.		
Kerry	introduces	herself	and	utilizes	light,	appropriate	humor	to	help	put	Kiana	
at	ease.	“The	labor	induction	process	can	take	several	hours	sometimes.	If	you	get	
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bored	and	I’m	not	in	another	patient’s	room,	I’d	be	happy	to	provide	you	with	a	special	
‘Karaoke	Kerry’	performance.”	Another	nurse,	Bobbi,	chimes	in	and	says,	“Trust	me,	
you	don’t	want	to	hear	any	of	that	–	‘Karaoke	Kerry’	is	not	as	talented	as	she	thinks	she	
is.”	Kerry	and	Kiana	share	a	laugh	together,	which	helps	Kiana	feel	more	comfortable	
and	connected	to	her	unfamiliar	surroundings.		
	Kerry	begins	with	the	routine	intake	evaluation,	starting	with	less	stressful	
screening	questions,	like	smoking	cigarettes.	“Kiana,	do	you	smoke	cigarettes	or	use	
any	tobacco	products?	If	so,	how	often?”	Kiana	quietly	responds	that	she	does	smoke	
cigarettes,	about	four	to	five	times	per	week.	Kerry	responds	by	offering	to	get	Kiana	a	
nicotine	patch	to	use	during	her	admission,	which	Kiana	declines	for	now.	Kerry	tells	
Kiana,	“If	at	any	point	you	feel	like	you	need	one,	just	let	us	know.	The	labor	induction	
process	can	be	stressful	and	take	a	long	time.	I’m	here	to	support	you	through	this	
process,	so	please	do	not	hesitate	to	use	the	call	bell	to	let	me	know	if	you	change	your	
mind.	Kerry	is	aware	that	hospitalizations	come	with	several	stressful	stimuli	that	can	
contribute	to	traumatic	experiences.	Kerry	reminds	Kiana	throughout	her	labor	
induction,	“Whatever	you	need,	I’m	here	for	you.”	
Kerry	moves	forward	with	the	intake	process	and	reviews	Kiana’s	medication-
assisted	treatment	management.	Kiana	still	feels	a	bit	nervous,	but	Kerry’s	warmth	
and	humanistic	approach	to	care	helps	to	put	Kiana	at	ease.	Kerry	answers	all	of	
Kiana’s	questions	with	transparency.		This	is	especially	important	in	regard	to	
toxicology	screenings,	NAS	monitoring,	and	child	welfare	involvement.	Kerry	is	also	
sure	to	ask	if	there	will	be	any	visitors	who	are	unaware	of	Kiana’s	recovery.	Kiana	
explains	that	her	mother	and	boyfriend	are	aware,	but	her	two	younger	sisters	are	not.	
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She	asks	that	no	one	mentions	this	in	front	of	them.	Kerry	assures	Kiana	that	this	
information	will	be	noted	in	her	chart	and	included	in	all	handoffs,	further	fostering	
safety	and	respect.		
	
N:	NEUTRALITY	
	 The	fifth	element	of	the	PARTNER	model	is	neutrality.	Neutrality	is	characterized	by	fully	objective,	nonjudgmental	care	and	is	maintained	through	self-awareness	and	self-evaluation.	All	patients	have	the	right	to	objective	healthcare	that	is	free	from	judgment,	prejudice,	and	bias.	This	is	especially	important	for	providers	working	with	pregnant	and	postpartum	women	with	opioid	use	disorders,	as	the	stigma	they	experience	is	amplified.	This	marginalized	group	of	postpartum	women	endure	all	the	standard	postpartum	challenges	while	simultaneously	drowning	in	disapproval	and	judgment	that	is	so	brazenly	conveyed	by	others,	especially	hospital	staff	members.	There	is	concrete,	measurable	weight	and	influence	in	the	way	in	which	a	patient	believes	he	or	she	is	perceived	by	a	person	in	an	authoritative	position.	Providers	are	inherently	viewed	as	powerful.	Internalized	feelings	of	guilt	and	shame	are	amplified	by	the	judgment	and	stigma	imparted	on	them	by	providers.	Providers	have	an	ethical	responsibility	to	develop	and	maintain	self-awareness	to	mitigate	implicit	bias	and	countertransference.	When	faced	with	any	internal	challenges	that	could	compromise	the	integrity	and	neutrality	of	their	work,	providers	should	seek	consultation.		
CASE	STUDY	VIGNETTE	
After	several	hours	of	labor	induction,	Kiana	gives	birth	to	a	healthy	baby	boy	
named	William.	William	was	immediately	placed	on	Kiana’s	chest	,	initiating	early	
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attachment	bonds	straightaway	from	birth	by	promoting	skin-to-skin	Kangaroo	care.	
Kiana’s	nurse,	Bobbi,	taught	her		how	to	swaddle	the	baby	and	provided	her	with	
breastfeeding	education	and	support.	Kiana	and	William	are	being	given	objective,	
unbiased	treatment	that	all	mothers	and	babies	deserve.		
Kiana’s	providers	are	mindful	of	their	language	choice.	During	morning	rounds,	
the	team	identifies	that	Kiana	is	on	medication-assisted	treatment,	which	requires	an	
extended	admission	for	William	to	monitor	for	NAS	symptoms.	They	never	refer	to	
Kiana	as	a	“drug	mom”	or	“Subutex	mom.”	They	never	refer	to	William	as	a	“drug	
baby”	or	a	“Subutex	baby.”	The	team	prioritizes	destigmatizing,	person-first	language.	
The	team	consistently	respects	Kiana’s	wishes	in	regard	to	who	can	be	present	during	
sensitive	discussions.		
The	postpartum	hospital	social	worker,	Danielle,	stops	by	Kiana’s	room	to	
introduce	herself	and	congratulate	Kiana	on	the	birth	of	her	baby.	“Hi	Kiana,	my	name	
is	Danielle.	It’s	so	nice	to	finally	meet	you.	I’m	one	of	the	postpartum	social	workers	
that	works	with	Allison.	I’m	not	sure	if	you	remember	her;	you	met	her	a	few	months	
ago.”	Kiana	remembers	Allison,	the	social	worker	who	helped	her	get	connected	to	the	
perinatal	addiction	medicine	and	ob/gyn	clinics.	Kiana	remembers	Allison’s	kind,	
nonjudgmental	demeanor.	Through	the	use	of	warm	handoffs,	Kiana’s	provider	team	is	
able	to	preserve	and	build	upon	these	connections	and	relationships.	
	Danielle	continues,	“Allison	is	off	until	Wednesday,	but	she	let	me	know	you	
were	scheduled	for	induction	this	week.	She’s	so	bummed	about	missing	you,	but	she	
will	be	back	before	you	leave.	I	don’t	want	to	interrupt	your	bonding	time	with	William	
now,	so	I	will	come	back	tomorrow.	Is	there	any	particular	time	that	you’d	prefer?”	By	
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integrating	these	aspects	of	neutrality	and	connection	into	her	care,	Kiana’s	
healthcare	providers	have	created	a	safe	space	where	she	can	truly	enjoy	her	first	
moments	of	motherhood	with	humanity,	dignity,	and	respect,	free	from	bias	and	
judgment.		
E:	EMPOWERMENT	
	 The	sixth	element	of	the	PARTNER	model	is	empowerment.	Empowerment	is	characterized	by	the	promotion	of	self-worth	and	autonomy.	To	truly	empower	patients,	providers	first	need	to	recognize	and	break	down	influences	of	stigma	to	promote	worthiness	of	self.	The	stigma	of	addiction	as	a	moral	failing	can	permeate	into	the	patient’s	belief	in	their	deservingness	of	motherhood.	At	the	most	basic	level	of	humanity,	the	patient	still	has	the	right	to	be	a	person.		
	 The	way	in	which	providers	work	toward	creating	a	sense	of	empowerment	in	patients	needs	to	be	individualized	and	person-centered,	especially	in	the	context	of	perinatal	opioid	use	disorders.	In	order	for	patients	to	experience	a	sense	of	empowerment,	providers	should	provide	proactive	psychoeducation	and	tools	to	promote	autonomous	and	informed	decision-making.	This	is	especially	important	in	the	transparency	mandated	reporting	laws	and	policies,	as	well	as	potential	child	welfare	outcomes.	The	education,	support,	and	encouragement	needs	to	be	applicable	and	appropriate	for	each	individual	patient’s	situation	and	circumstances.	For	example,	the	ability	to	safely	breastfeed	the	baby	may	not	be	possible	for	some	patients	depending	on	active	opioid	use	and/or	contraindicated	medications.	In	this	type	of	situation,	providers	should	identify	other	ways	to	empower	the	patient	without	shaming	or	diminishing	self-worth.	
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CASE	STUDY	VIGNETTE	
The	following	day,	Danielle	returns	to	meet	with	Kiana.	Danielle	is	aware	that	
although	she	briefly	met	with	Kiana	yesterday,	she	needs	to	continue	to	establish	
rapport	with	Kiana.	Danielle	engages	with	Kiana,	giving	Kiana	the	opportunity	to	
process	her	feelings	about	her	pregnancy,	labor,	and	first	childbirth	experience.	
Danielle	connects	with	Kiana	over	the	baby’s	name,	sharing	that	her	best	friend’s	name	
is	William.		
Danielle’s	assessment	covers	several	areas,	including	evaluating	for	access	to	
basic	needs,	infant	preparedness,	social	supports,	and	postpartum/newborn	
psychoeducation.	Danielle	also	reviews	clinical	assessment	information,	including	
mental	health	history,	postpartum	depression	screening,	intimate	partner	violence,	
substance	use	history,	and	mandated	reporting	laws.	Kiana	is	already	aware	of	
mandated	reporting	laws	and	required	child	protective	services	report.	She	remembers	
having	this	discussion	with	Jenny	during	one	of	her	prenatal	care	visits.		
Kiana	shares	with	Danielle	that	she	feels	well-prepared	for	this	process,	but	she	
is	still	afraid.	Kiana	discloses	feelings	of	shame	and	guilt.	She	reveals	to	Danielle,	“I	feel	
like	I’m	a	bad	person	and	a	bad	mom.	William	deserves	better	than	me.	It’s	my	fault	
that	he	has	to	go	through	withdrawal.	I	know	what	that	feels	like,	and	I	can’t	believe	
my	mistakes	are	causing	my	baby	to	feel	that	way.	I	don’t	want	anyone	to	think	I	don’t	
love	my	baby.”		
Danielle	recognizes	Kiana’s	addiction	and	child	protective	service	involvement	
is	not	new	information,	but	this	information		has	new	context	now	that	the	baby	has	
been	born.	Danielle	gives	Kiana	the	space	to	talk	through	and	process	these	feelings,	
 80 
while	utilizing	supportive	counseling	and	cognitive-behavioral	techniques	to	work	
toward	mitigating	the	cognitive	distortions.	Danielle	works	together	with	Kiana	to	
reframe	her	thoughts,	highlighting	Kiana’s	growth,	protective	factors,	and	resilience.		
Most	importantly,	Danielle	reassures	Kiana	that	she	is	an	integral	part	of	
William’s	care	team,	reminding	her	that	maternal	engagement	and	early	attachment	
bond	development	is	scientifically	shown	to	positively	impact	NAS	treatment	outcomes	
and	early	childhood	development.	By	doing	this,	Danielle	is	working	toward	restoring	
Kiana’s	self-worth	and	empowering	her	to	be	an	active	participant	in	William’s	care.	
	
R:	REINFORCEMENT	The	seventh	and	final	element	of	the	PARTNER	model	is	reinforcement.	Reinforcement	is	characterized	by	repetition	and	consistency.	Patients	regularly	do	not	retain	most	of	the	information	they	receive	from	their	healthcare	providers.	This	is	especially	evident	in	the	setting	of	stressful	stimuli,	which	directly	impacts	memory	function.	Stressful	stimuli	can	also	activate	maladaptive	self-defense	mechanisms,	self-destructive	cognitive	distortions,	and	denial.	When	faced	with	unpleasant	circumstances,	patients	may	also	subconsciously	pick	certain	pieces	of	information	to	remember	or	ignore	to	appease	the	ego.	Providers	should	be	willing	to	review	education	and	information	in	various	formats	to	meet	their	patient’s	needs.	The	process	of	repetition	should	be	approached	with	patience,	anticipation,	and	empathy.				 Providers	should	also	be	providing	consistent	information	with	a	united	approach	to	care.	This	practice	is	integral	to	this	model,	as	it	fosters	trust	and	reduces	ambiguity.	Consistency	is	especially	important	when	discussing	sensitive	topics	including	infant	
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withdrawal	monitoring	protocol,	NAS,	and	child	protective	service	involvement.		Providing	consistent	information	is	not	only	ethically	imperative,	but	it	aids	in	reducing	ambiguity	for	the	patient.	Consistency	can	be	cultivated	through	wraparound	support	approaches	and	warm	handoffs	to	ensure	continuity	of	care.	
	
CASE	STUDY	VIGNETTE	
	 It	is	the	discharge	day	for	Kiana,	but	William’s	admission	continues	for	NAS	
monitoring.	Kiana	knows	this	day	was	going	to	come,	but	it	still	doesn’t	feel	real.	After	
Kiana	is	formally	discharged	from	the	hospital,	William	is	transferred	to	the	nursery,	
where	he	will	remain	for	at	least	the	next	two	days.	William	may	need	to	stay	for	
longer,	depending	on	his	withdrawal	symptoms.	Kiana	returns	to	her	mother’s	home	to	
unpack	her	bags	and	take	a	shower	but	returns	to	the	hospital	shortly	afterward	to	
stay	by	William’s	side.	When	Kiana	arrives	at	the	nursery,	she	feels	overcome	with	
doubt,	asking	herself,	“Do	I	even	belong	here?	Do	I	even	deserve	to	be	a	mom?”	
	 Moments	after	entering	the	nursery,	Kiana	is	greeted	by	William’s	nurse,	Steph.	
“Hi	Kiana,	my	name	is	Steph	and	I’ll	be	taking	care	of	William	with	you	today.	You’re	
just	in	time	for	rounds!	This	is	Robert,	the	attending	pediatrician.”	Robert	turns	to	
Kiana,	extending	his	arm	and	gesturing	to	Kiana	to	come	join	the	discussion.	Steph	and	
Robert	are	aware	of	how	intimidating	this	environment	can	feel.	They	know	Kiana	has	
been	educated	on	the	benefits	of		early	attachment	bonding,	but	they	are	reinforcing	
this	message	to	engage	her	as	an	active,	important	member	of	the	baby’s	treatment	
team.		
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	 Steph,	Robert,	and	other	members	of	the	team	include	Kiana	in	the	care	
planning	discussion	during	rounds.	They	review	William’s	newborn	delivery	notes	and	
his	treatment	plan,	consistently	using	person-first,	destigmatizing	language.	Robert	
reviews	NAS	scoring	protocol	with	Kiana,	showing	her	the	Modified	Finnegan	NAS	
Scoring	Sheet	as	they	discuss	William’s	scores	over	the	past	24	hours.	Robert	knows	
Kiana	has	been	educated	on	the	NAS	scoring	process.	However,	he	also	understands	
the	benefit	of	repetition,	especially	considering	the	significant	stimuli	exposure	Kiana	
has	experienced	over	the	past	few	days.		
Steph	reviews	Kiana’s	breastfeeding	plan,	pausing	every	so	often	to	create	the	
opportunity	for	equal	partnership	discussion	and	questions.	Feeling	comfortable	as	a	
member	of	the	care	team,	Kiana	asks,	“Is	it	definitely	safe	for	me	to	breastfeed	with	the	
Subutex?”	Steph	knows	Kiana	has	been	educated	on	the	efficacy	and	safety	of	
breastfeeding	while	taking	Subutex,	but	she	also	recognizes	the	importance	of	
reinforcement	and	conveying	consistent	messages.	Steph	provides	her	with	
reassurance,	validation,	and	offers	to	bring	in	one	of	the	lactation	consultants	for	
ongoing	breastfeeding	support.		
At	the	end	of	rounds,	the	team	asks	Kiana	if	she	has	any	other	questions.	Kiana	
replies,	“Is	it	okay	to	hold	him?”		Robert	picks	William	up	out	of	his	hospital	crib	and	
hands	him	to	Kiana	with	a	warm	smile.	He	says	to	her,	“William	is	such	a	lucky	boy	to	
have	you	as	his	mom.”	
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CHAPTER	VI:	CONCLUSION	
CONCLUDING	STATEMENT		 The	need	for	an	evidence-informed	approach	like	the	PARTNER	model	is	evident.	The	PARTNER	model	is	the	first	research-informed,	systematically	developed	practice	model	designed	to	specifically	address	the	unique	needs	of	mothers	and	babies	impacted	by	the	perinatal	opioid	epidemic.	It	is	intended	to	be	as	comprehensive	as	possible,	but	it	is	not	a	finite,	independent	solution	this	macro-level	problem.	There	are	countless	potential	combinations	of	demographics,	risk	factors,	and	comorbidities	that	could	impact	the	way	in	which	the	PARTNER	model	is	integrated	into	practice.		Future	recommendations	include	the	development	of	a	structured	curriculum	to	educate	providers	on	each	of	the	elements	of	the	PARTNER	model	and	how	to	effectively	integrate	them	into	clinical	practice.	Future	recommendations	also	include	both	short-term	and	longitudinal	evaluation	of	the	PARTNER	model,	with	possible	areas	of	focus	including	changes	in	mother/infant	bonding,	maternal	engagement	in	care,	NAS	treatment	outcomes,	and	a	length	of	stay	cost/benefit	analysis.			 Though	the	efficacy	of	the	PARTNER	model	has	not	yet	been	empirically	measured,	it	is	a	clinically	valuable	and	innovative	approach	that	fills	a	deep,	destructive	gap	in	current	practice	in	working	with	mothers	and	infants	impacted	by	perinatal	opioid	use	disorders.	The	value	and	impact	of	early	attachment	bonding	cannot	be	underestimated.	Early	attachment	bonding	creates	a	pathway	for	the	way	in	which	individuals	engage	in	human	relationships	across	the	lifespan.	Continuing	the	current	practices	of	alienating,	ostracizing,	and	stigmatizing	pregnant	and	postpartum	women	with	opioid	use	disorders	will	only	perpetuate	this	cycle	of	separation,	disconnection,	and	fear.		
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By	integrating	the	PARTNER	model	into	the	standard	of	care,	healthcare	providers	can	help	mothers	and	infants,	like	Kiana	and	William,	by	working	toward	breaking	down	the	socially-created	barriers	of	stigma	and	fear	that	interfere	with	early	attachment	bonding,	an	essential	aspect	of	human	development	that	deserves	to	be	regarded	as	a	basic	human	right.				 				
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